IL-13 receptor-alpha2: a novel target for cancer therapy.
Joshi
Bharat H
BH
Puri
Raj K
RK
D000818:Animals; D000970:Antineoplastic Agents / Q000276:immunology / Q000378:metabolism*; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000276:immunology / Q000378:metabolism; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007167:Immunotherapy; D053663:Interleukin-13 Receptor alpha2 Subunit / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D050800:STAT6 Transcription Factor / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology; D058408:Th1-Th2 Balance / Q000187:drug effects
D000970:Antineoplastic Agents; D016207:Cytokines; D053663:Interleukin-13 Receptor alpha2 Subunit; D050800:STAT6 Transcription Factor